- Reckitt Benckiser Group PLC RBGLY said Q2 like-for-like revenue rose 11.9% on a constant currency basis, beating the 6.8% growth analysts had expected in a company-supplied poll.
- Reckitt hiked prices 9.7% in the quarter, while sales volumes were up 2.2%.
- Q2 sales increased 5.9% on constant currency to £3.46 billion, including a 3.3% boost from sales of its Enfamil baby formula amid a shortage of supplies in the U.S. after Abbott Laboratories ABT recalled dozens of brands in February.
- Related: More Companies Join Race To Ease US Baby Formula Supply Crunch.
- "We've clearly seen the supply situation help us with regard to overall market share," CEO Laxman Narasimhan said. "We will see some normalization as a competitor comes back online, but we have a business with a brand that's the number one recommended brand," as per Reuters.
- Guidance: Reckitt expects like-for-like net revenue growth of 5-8% for 2022 and growth in adjusted operating margins.
- In April, it had forecast net revenue growth in the upper part of a 1-4% range and margins in line with last year.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.